POSTER SESSION II
Monday, March 22, 2010   1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
28
Morphologic Features of Breast Carcinoma Are Associated with False Negative Screening by Axillary Ultrasound
(209)
TT Ha, S Charoenthammaraksa, C Liao, RA Schmidt, HA Sattar - University of Chicago, Chicago, IL
Histologic Characteristics of Benign Breast Lesions Identified for Biopsy by Magnetic Resonance Imaging
(231)
MM Johnson, V Dialani, NB Johnson - Massachusetts General Hospital, Boston, MA; Beth Israel Deaconess Medical Center, Boston, MA
High Diagnostic Accuracy of FNAC Performed in a One Stop Clinic for the Diagnostic for Breast Lesions: A 3-Years Experience with 1822 Specimens
(332)
P Vielh, I Borget, C Caramella, C Balleyguier, V Suciu, C Uzan, J Domont, M Mathieu, C Dromain, S Delaloge - Institut de Cancerologie Gustave Roussy, Villejuif, France
Coronal Serial Sectioning of Lumpectomy Specimens: Proposed Technique of Sectioning and Submission of Tissue for Microscopic Examination of Breast Carcinoma
(141)
MS Amin, C Bicamampuka, J Swift, BF Burns, KT Mai - University of Ottawa, Ottawa, ON, Canada; The Ottawa Hospital, Ottawa, ON, Canada
Flat Epithelial Atypia Is a Common Subtype of B3 Breast Lesions and Associated with Non-Invasive Cancer but Not with Invasive Cancer in Final Excision Histology
(277)
A Noske, S Pahl, C Richter-Ehrenstein, E Fallenberg, AC Buckendahl, C Denkert - Universitatsspital Zurich, Zurich, Switzerland; Charite, Berlin, Germany
Columnar Cell Lesions and Flat Epithelial Atypia in Breast Biopsies Performed Due to the Presence of Mammographic Suspicious Abnormalities
(183)
M De Brot, CB Nunes, H Gobbi - Federal University of Minas Gerais - UFMG, Belo Horizonte, Minas Gerais, Brazil
Columnar Cell Lesions of the Breast: Association with Other Types of Fibrocystic Change and Distribution in Hispanic and Non-Hispanic White Women
(258)
L Lomo, M Myrsiades, A Nibbe, T Bocklage, D Hill - University of New Mexico School of Medicine, Albuquerque, NM
ER+PR- Breast Carcinomas Are More Frequently Associated with Older Patients, Larger Tumors and HER2 Positive Tumors
(325)
P Tai, J Wang, P Ding, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solutions, Research Triangle Park, NC
Significance of Partial Reverse Cell Polarity in Breast Cancer - Part of a Spectrum of Micropapillary Carcinoma?
(131)
G Acs, NN Esposito, Z Rakosy, C Laronga, PJ Zhang - Moffitt Cancer Center, Tampa, FL; Women's Pathology Consultants, Ruffolo Hooper & Associates, Tampa, FL; University of Pennsylvania Medical Center, Philadelphia, PA
Infiltrative Epitheliosis of the Breast: Clinicopathological Review of Seven Cases of "A Pseudoinfiltrative Epitheliosis"
(220)
MJ Horne, N Buza, FA Tavassoli - Yale-New Haven Hospital, New Haven, CT
Primary Breast Malignant Fibrous Histiocytoma: A Clinicopathologic Review of 19 Cases with Two New Variants
(212)
PH Hartel, G Bratthauer, JV Hartel, T Vinh, JC Fanburg-Smith - Davis Memorial Hospital, Elkins, WV; AFIP, Washington, DC; Covenant Medical Center, Waterloo, IA
Mammary Adenomyoepitheliomas May Feature Basal/Spindle Cells with an Uncommitted Epithelial Phenotype: Biologic and Diagnostic Implications
(217)
BC Ho, IO Ellis - Nottingham City Hospital, Nottingham, United Kingdom; Tan Tock Seng Hospital, Singapore, Singapore
Histopathology of the Male Breast: Eleven Years Experience of the Vanderbilt Breast Consultation Service
(306)
ME Sanders, SA Manning, JA Smith, JF Simpson, DL Page - Vanderbilt University, Nashville, TN
Molecular Classification of Male Breast Cancer Using Immunohistochemistry
(135)
G Al-Saati, KC Jensen - King Saud University, Riyadh, Saudi Arabia; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA; Stanford University Hospital, Stanford, CA
Epidermal Growth Factor Receptors and Topoisomerase II Alpha in Primary Adenoid Cystic Carcinomas of the Breast
(333)
S Vranic, S Frkovic-Grazio, N Bilalovic, JP Palazzo, Z Gatalica - Creighton University School of Medicine, Omaha, NE; Institute of Oncology, Ljubljana, Slovenia; University Clinical Center, Sarajevo, Bosnia and Herzegowina; Jefferson Medical Center, Philadelphia, PA
Breast Carcinoma Following Treatment of Hodgkin Lymphoma: A Study of 31 Patients
(205)
A Goyal, C Mies - Hospital of the University of Pennsylvania, Philadelphia, PA
Histological Grading of Breast Carcinoma: Variability between Breast Subspecialty Pathologists and General Pathologists
(345)
K Woolf, J Wang, X Wang, LM Schiffhauer, DG Hicks, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solutions, Research Triangle Park, NC
Markers of Metastatic Breast Cancer: Correlations between GCDFP-15 or Mammaglobin Expression and Tumor Grade, Hormone Receptor, and HER2 Expression
(204)
AM Gown, LC Goldstein, PL Kandalaft, HC Hwang, SJ Kussick, CC Tse - PhenoPath Laboratories, Seattle, WA; IMPRIS, Seattle, WA
P75/P63; a Novel Immunohistochemical Cocktail Which Is Diagnostically Superior to P63 for the Evaluation of Myoepithelial Cells in Challenging Breast Lesions
(178)
SJ Conlon, DE McCrae, SC Chak, SM Moran, FP O'Connell, TJ Browne - Cork University Hospital, Cork, Ireland
Mammaglobin Distinguishes Cutaneous Metastasis of Breast Cancer from Primary Cutaneous Adnexal Tumors
(331)
ME Vergara, TH McCalmont, YY Chen, JT Rabban - UCSF, San Francisco, CA
Beta-Catenin/WNT Signaling Pathway in Fibromatosis, Metaplastic Carcinomas and Phyllodes Tumours of the Breast
(198)
FC Geyer, M Lacroix-Triki, K Savage, AH Lee, JS Reis-Filho - ICR, London, United Kingdom; Institut Claudius Regaud, Toulouse, France; Nottingham City Hospital, Nottingham, United Kingdom
Reevaluation and Identification of the Best Immunohistochemical Panel for Differentiating Breast Ductal Adenocarcinoma from Pancreatic Adenocarcinoma
(254)
H Liu, J Shi, JW Prichard, F Lin - Geisinger Medical Center, Danville, PA
From the Bin to the Gene: Leftovers of Diagnostic Fine Needle Aspiration Cytology Can Be Successfully Used To Perform Gene Expression Profiling of Breast Carcinomas
(144)
L Annaratone, C Marchio, I Castellano, D Cantarella, E Allia, G Bussolati, E Medico, A Sapino - University of Turin, Turin, Italy; Institute for Cancer Research and Treatment, Turin, Italy
Breast Cancer Molecular Subtype Classification: A Comparison of Three Microarray-Based Single Sample Predictors
(338)
B Weigelt, A Mackay, R Natrajan, DS Tan, A Ashworth, JS Reis-Filho - CRUK London Research Institute, London, United Kingdom; ICR, London, United Kingdom
Quantitative Gene Expression by RT-PCR in the Special Histologic Subtypes of Estrogen Receptor Positive Invasive Breast Cancer
(150)
FL Baehner, D Watson, J Anderson, C Millward, I Chen, S Shak - University of California, San Francisco, San Francisco, CA; GHI, Redwood City, CA
A Large-Scale Tissue Microarray Study Confirms the Prognostic Value of P-Cadherin Expression in Breast Cancer and Association with Her2+ and Basal Subtypes
(329)
G Turashvili, S McKinney, O Goktepe, S Leung, D Huntsman, S Aparicio - BC Cancer Research Centre, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada
PTEN Loss of Expression Is Not Related with PTEN Promoter Hypermethylation in HER2-Positive Breast Carcinoma
(200)
D Giner, L Sanchez-Tejada, FJ Gutierrez-Avino, L Perez-Carbonell, FI Aranda, E Lerma, L Catasus, G Peiro - Hospital General Universitari, Alacant, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Luminal A Versus Luminal B Tumors: Significance of Proliferation Index in ER Positive HER2 Negative Tumors
(264)
E Marchetti, D Dabbs, J Yu, S Beriwal, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA
Cortactin Gene Amplification and Expression in Breast Cancer
(259)
MA Lopez-Garcia, FC Geyer, MB Lambros, R Vatcheva, R Natrajan, KK Dedes, JS Reis-Filho - ICR, London, United Kingdom
ER/PR and Her2/Neu Correlation between Immunohistochemisty and Gene Expression Profiling in Women with Invasive Breast Cancer
(188)
M Dydo, J Shutter - University of South Florida, Tampa, FL
PPM1D Overexpression and Gene Amplification in Breast Cancers: A QRT-PCR and Chromogenic In Situ Hybridization Study
(249)
MB Lambros, R Natrajan, FC Geyer, MA Lopez-Garcia, K Savage, M Lacroix-Triki, JS Reis-Filho - ICR, London, United Kingdom; Institut Claudius Regaud, Toulouse, France
Increased Erythropoietin Receptor Expression Is Associated with Distinct Gene Expression Profile in Human Breast Cancer
(290)
Z Rakosy, G Paragh, G Acs - Moffitt Cancer Center, Tampa, FL; Women's Pathology Consultants, Ruffolo Hooper & Associates, Tampa, FL
Drosha and Dicer Down-Regulation in Breast Cancer: A QRT-PCR Analysis
(274)
R Natrajan, F Geyer, MB Lambros, MA Lopez-Garcia, K Savage, JS Reis-Filho - Institute of Cancer Research, London, United Kingdom; Hospital Universitario Virgen del Rocio, Seville, Spain
Calretinin Expression in Poorly Differentiated Breast Carcinomas with an Emphasis on the Basal-Like Subtype
(315)
K Singh, H Sidhu, S Mangray, R Tavares, L Noble, M Resnick, R DeLellis, E Yakerewich - Brown University, Providence, RI
Expression, Regulation and Function of Myoglobin in Breast Cancer
(246)
G Kristiansen, J Hu, D Stiehl, M Rose, J Gerhardt, FR Fritzsche, H Moch, JP Theurillat, E Gnaiger, T Hankeln, TA Gorr, E Dahl - University of Zurich, Zurich, Switzerland; University Hospital of the RWTH Aachen, Aachen, Germany; Medical University of Innsbruck, Innsbruck, Austria; Johannes Gutenberg University Mainz, Mainz, Germany
A Comparative Study of p16 Expression in Basal-Like Carcinoma and High-Grade Invasive Ductal Carcinoma of the Breast
(158)
OL Bohn, M Fuertes-Camilo, L Navarro, J Saldivar, S Sanchez-Sosa - Christus Muguerza UPAEP University Hospital/Hospital Angeles, Puebla, Mexico
Biomarker Expression Can Identify Biologically Distinct Categories of Invasive Breast Cancer
(312)
JY Shim, R Zhou, PA Thompson, AM Brewster, JL Murray, ME Edgerton, N Karadag, ML Bondy, A Sahin - MD Anderson Cancer Center, Houston, TX; Arizona Cancer Center, Tucson, AZ